Skip to main content
. Author manuscript; available in PMC: 2014 Apr 27.
Published in final edited form as: JAMA Neurol. 2014 Mar;71(3):315–323. doi: 10.1001/jamaneurol.2013.5570

Table 8.

APOE-Stratified Incidence Rate of AD

Age Group, y No APOE e4 Allele
1 or 2 Copies of APOE e4 Allele
No. of Cases Person-years at Risk Incidence Rate (95% CI) No. of Cases Person-years at Risk Incidence Rate (95% CI)
NIA-LOAD/NCRAD Families

65–74 10 558 0.02 (0.01–0.03) 21 543 0.04 (0.002–0.06)

75–84 13 409 0.03 (0.02–0.05) 30 340 0.09 (0.06–0.13)

≥85 10 221 0.05 (0.02–0.08) 9 81 0.11 (0.05–0.21)

EFIGA Families

55–64 9 551 0.02 (0.01–0.03) 10 347 0.03 (0.01–0.05)

65–74 25 600 0.04 (0.03–0.06) 31 55 0.06 (0.04–0.08)

75–84 28 396 0.07 (0.05–0.10) 26 309 0.08 (0.06–0.12)

≥85 10 152 0.07 (0.03–0.12) 6 72 0.08 (0.02–0.16)

Abbreviations: AD, Alzheimer disease; APOE, apolipoprotein E; EFIGA, Estudio Familiar de Influencia Genetica en Alzheimer; NIA-LOAD/NCRAD, National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease.